- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-24-0000296

About Lactose (India) Limited
Data last updated:
Lactose (India) Limited is a public limited company based in Poicha, Gujarat, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 11 March 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L15201GJ1991PLC015186. Its GSTIN is 24AAACL2595G1ZL (Gujarat). The company holds 4 GST registrations, of which 2 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 524202.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹12.59 Cr. It is led by directors including Atul Maheshwari (Managing Director) and Sangita Maheshwari (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Survey No.5 6 & 7A Village – Poicha (Rania). Taluka Savli District Vadodara, Gujarat, India – 391780.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹163.29 Cr, a growth of 40.3% compared to the previous year. For the same year it recorded a net profit of ₹6.06 Cr (net margin 3.7%) and EBITDA of ₹18.38 Cr (EBITDA margin 11.3%). The net worth stands at ₹64.8 Cr (up 10.3% YoY). Total assets are valued at ₹128.94 Cr (up 10.1% YoY).
The company has about 136 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lactose India. As per MCA filings, the company has open charges of ₹96.17 Cr and satisfied charges of ₹230.31 Cr on record. Court records list 44 cases involving the company, including 13 filed by the company and 31 filed against it; 12 cases are pending. The company has 8 deals on record (8 market trades); the latest was in February 2024. Its 9 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Kimia Biosciences Limited with revenue of ₹120.24 Cr. The company has 13 MSME Form 1 returns on record between 2018 and 2024, listing 393 overdue payments to 40 micro and small suppliers.
Lactose (India) Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0000296). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lactoseindialimited.com.
Company details
CIN history
Lactose (India) has one previous CIN (Corporate Identification Number): U15201GJ1991PLC015186. The current CIN is L15201GJ1991PLC015186, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L15201GJ1991PLC015186 | Current |
| U15201GJ1991PLC015186 | Previous |
Recognitions & Rankings of Lactose (India)
Contact details
Lactose (India) Limited's registered office is in Poicha, Gujarat. Its website is lactoseindialimited.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSurvey No.5 6 & 7A Village – Poicha (Rania). Taluka Savli District Vadodara, Gujarat, India – 391780
- IndustryPharma, API Manufacturers
To see the full contact details of Lactose (India) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Lactose (India) operates one associated brand: Lactose India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical excipients including lactose and dosage forms are manufactured. | lactoseindialimited.com |
Business activity
The main business activity of Lactose (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lactose (India) Limited, buy the company report.
Financials of Lactose (India) Limited
FY 2025-26 filings availableLactose (India) Limited reported revenue of ₹163.29 Cr (up 40.3% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 163 | 116 | 114 | 65.80 | 45.94 | 34.96 | 40.05 |
| Revenue growth | +40.3% | +2.2% | +73.1% | +43.2% | +31.4% | -12.7% | - |
| EBITDA | 18.38 | 16.96 | 19.01 | 11.38 | 12.27 | 6.23 | 9.26 |
| EBITDA margin | +11.3% | +14.6% | +16.7% | +17.3% | +26.7% | +17.8% | +23.1% |
| Profit before tax | 8.62 | 6.92 | 9.66 | 1.46 | 3.17 | (3.27) | 0.09 |
| Net profit | 6.06 | 5.13 | 6.77 | 1.18 | 2.42 | (2.48) | 0.06 |
| Net profit margin | +3.7% | +4.4% | +5.9% | +1.8% | +5.3% | -7.1% | +0.2% |
| EPS (₹) | 4.68 | 4.10 | 5.39 | 0.96 | 1.95 | (2.17) | 0.07 |
| Balance sheet | |||||||
| Total assets | 129 | 117 | 87.82 | 79.96 | 81.56 | 82.82 | 75.85 |
| Net worth | 64.80 | 58.75 | 47.10 | 40.56 | 39.29 | 35.09 | 34.29 |
| Total debt | 62.45 | 56.83 | 39.25 | 38.46 | 41.33 | 46.14 | 39.44 |
| Cash & bank | 0.74 | 4.93 | 1.86 | 0.92 | 2.08 | 2.66 | 1.88 |
| Net working capital | 47.93 | 43.33 | 24.44 | 16.76 | 14.68 | 14.63 | 12.93 |
| Cash flow | |||||||
| Cash from operations | 5.56 | (0.29) | 8.75 | 7.89 | 8.47 | 2.16 | 7.41 |
| Cash from investing | (10.22) | (15.57) | (2.08) | (0.92) | (0.56) | (6.18) | (2.88) |
| Cash from financing | 0.71 | 18.81 | (5.72) | (8.32) | (8.14) | 4.52 | (3.57) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 46.97 | 45.77 | 36.77 | 41.18 | 39.58 | 27.77 | 28.72 | 30.45 |
| Revenue growth (YoY) | +18.7% | +64.8% | +28.0% | +35.2% | +34.4% | - | - | - |
| Other income | 0.56 | 0.22 | 0.63 | 0.37 | 0.41 | 0.37 | 0.56 | 0.30 |
| Total expenses | 40.89 | 40.74 | 33.70 | 35.92 | 35.11 | 24.36 | 25.75 | 25.43 |
| EBITDA | 6.08 | 5.03 | 3.07 | 5.26 | 4.47 | 3.41 | 2.97 | 5.02 |
| EBITDA margin | +12.9% | +11.0% | +8.3% | +12.8% | +11.3% | +12.3% | +10.3% | +16.5% |
| Depreciation | 1.64 | 1.50 | 1.43 | 1.44 | 1.37 | 1.39 | 1.35 | 1.33 |
| Interest | 1.76 | 1.43 | 1.39 | 1.04 | 1.22 | 1.84 | 1.64 | 1.37 |
| Profit before tax | 3.24 | 2.32 | 0.88 | 3.15 | 2.29 | 0.55 | 0.54 | 2.62 |
| Tax | 0.87 | 0.43 | 0.35 | 0.98 | 0.79 | (0.10) | 0.32 | 0.58 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 46.97 | 45.77 | 36.77 | 41.18 | 39.58 | 27.77 | 28.72 | 30.45 |
| Revenue growth (YoY) | +18.7% | +64.8% | +28.0% | +35.2% | +34.4% | - | - | - |
| Other income | 0.56 | 0.22 | 0.63 | 0.37 | 0.41 | 0.37 | 0.56 | 0.30 |
| Total expenses | 40.89 | 40.74 | 33.70 | 35.92 | 35.11 | 24.36 | 25.75 | 25.43 |
| EBITDA | 6.08 | 5.03 | 3.07 | 5.26 | 4.47 | 3.41 | 2.97 | 5.02 |
| EBITDA margin | +12.9% | +11.0% | +8.3% | +12.8% | +11.3% | +12.3% | +10.3% | +16.5% |
| Depreciation | 1.64 | 1.50 | 1.43 | 1.44 | 1.37 | 1.39 | 1.35 | 1.33 |
| Interest | 1.76 | 1.43 | 1.39 | 1.04 | 1.22 | 1.84 | 1.64 | 1.37 |
| Profit before tax | 3.24 | 2.32 | 0.88 | 3.15 | 2.29 | 0.55 | 0.54 | 2.62 |
| Tax | 0.87 | 0.43 | 0.35 | 0.98 | 0.79 | (0.10) | 0.32 | 0.58 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 163 | 116 | 114 | 65.80 | 45.94 | 34.96 | 40.05 |
| Revenue growth | +40.3% | +2.2% | +73.1% | +43.2% | +31.4% | -12.7% | - |
| Other income | 1.07 | 1.45 | 1.12 | 0.72 | 0.58 | 0.31 | 0.30 |
| Total expenses | 145 | 99.44 | 94.88 | 54.42 | 33.67 | 28.73 | 30.79 |
| Employee cost | 0.00 | 10.50 | 8.72 | 6.57 | 12.25 | 10.63 | 11.88 |
| EBITDA | 18.38 | 16.96 | 19.01 | 11.38 | 12.27 | 6.23 | 9.26 |
| EBITDA margin | +11.3% | +14.6% | +16.7% | +17.3% | +26.7% | +17.8% | +23.1% |
| Depreciation | 5.74 | 5.39 | 5.22 | 4.69 | 4.56 | 4.36 | 3.91 |
| Interest | 5.09 | 6.10 | 5.25 | 5.95 | 5.12 | 5.45 | 5.56 |
| Profit before tax | 8.62 | 6.92 | 9.66 | 1.46 | 3.17 | (3.27) | 0.09 |
| Tax | 2.56 | 1.76 | 2.88 | 0.26 | 0.72 | (0.79) | 0.03 |
| Net profit | 6.06 | 5.13 | 6.77 | 1.18 | 2.42 | (2.48) | 0.06 |
| Net profit margin | +3.7% | +4.4% | +5.9% | +1.8% | +5.3% | -7.1% | +0.2% |
| EPS (₹) | 4.68 | 4.10 | 5.39 | 0.96 | 1.95 | (2.17) | 0.07 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 12.59 | 12.59 | 12.59 | 12.59 | 12.59 | 11.44 | 10.19 |
| Reserves & surplus | 45.68 | 39.63 | 34.51 | 27.97 | 26.70 | 23.05 | 24.10 |
| Shareholders' funds (net worth) | 64.80 | 58.75 | 47.10 | 40.56 | 39.29 | 35.09 | 34.29 |
| Secured loans | 60.09 | 56.19 | 38.07 | 38.30 | 40.96 | 42.88 | 38.55 |
| Unsecured loans | 2.36 | 0.64 | 1.18 | 0.16 | 0.37 | 3.26 | 0.89 |
| Total debt | 62.45 | 56.83 | 39.25 | 38.46 | 41.33 | 46.14 | 39.44 |
| Total liabilities | 129 | 117 | 87.82 | 79.96 | 81.56 | 82.82 | 75.85 |
| Assets | |||||||
| Gross block | 109 | 87.92 | 85.30 | 82.26 | 81.11 | 77.71 | 75.82 |
| Net block | 69.11 | 52.32 | 54.66 | 56.07 | 59.21 | 59.47 | 61.82 |
| Capital work in progress | 0.27 | 10.24 | 0.00 | 0.00 | 0.00 | 3.52 | 0.23 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.74 | 0.68 | 0.07 |
| Inventories | 55.95 | 24.55 | 16.79 | 22.78 | 7.12 | 8.32 | 8.91 |
| Sundry debtors | 33.46 | 21.64 | 15.40 | 12.49 | 11.35 | 6.43 | 6.98 |
| Cash & bank balances | 0.74 | 4.93 | 1.86 | 0.92 | 2.08 | 2.66 | 1.88 |
| Loans & advances | 8.48 | 6.20 | 1.40 | 1.22 | 2.20 | 2.29 | 2.04 |
| Total current assets | 98.63 | 57.32 | 35.45 | 37.41 | 22.75 | 19.70 | 19.81 |
| Total current liabilities | 50.70 | 13.99 | 11.01 | 20.65 | 8.07 | 5.07 | 6.88 |
| Net working capital | 47.93 | 43.33 | 24.44 | 16.76 | 14.68 | 14.63 | 12.93 |
| Total assets | 129 | 117 | 87.82 | 79.96 | 81.56 | 82.82 | 75.85 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 4.48 | 1.53 | 0.58 | 1.92 | 2.16 | 1.65 | 0.69 |
| Net cash from operating activities | 5.56 | (0.29) | 8.75 | 7.89 | 8.47 | 2.16 | 7.41 |
| Net cash from investing activities | (10.22) | (15.57) | (2.08) | (0.92) | (0.56) | (6.18) | (2.88) |
| Net cash from financing activities | 0.71 | 18.81 | (5.72) | (8.32) | (8.14) | 4.52 | (3.57) |
| Net change in cash | (3.95) | 2.95 | 0.95 | (1.34) | (0.24) | 0.51 | 0.96 |
| Closing cash | 0.74 | 4.93 | 1.86 | 0.92 | 2.08 | 2.66 | 1.88 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +40.3% | +2.2% | +73.1% | +43.2% | +31.4% | -12.7% | - |
| EBITDA growth | +8.4% | -10.8% | +67.1% | -7.3% | +97.0% | -32.7% | - |
| PBT growth | +24.6% | -28.4% | +561.6% | -53.9% | +9998.0% | - | -91.7% |
| Net income growth | +18.1% | -24.2% | +473.7% | -51.2% | +197.6% | -4233.3% | - |
| Revenue CAGR (3Y) | +35.4% | +36.3% | +48.2% | +18.0% | +4.2% | +4.0% | +4.0% |
| EBITDA CAGR (3Y) | +17.3% | +11.4% | +45.0% | +7.1% | +8.5% | +3.5% | -6.6% |
| Profitability & leverage | |||||||
| Net income margin | +3.7% | +4.4% | +6.0% | +1.8% | +5.3% | -7.1% | +0.2% |
| Return on capital employed | - | +12.7% | +17.8% | +9.2% | +10.1% | +2.8% | +7.6% |
| Return on net worth | - | +9.8% | +15.5% | +3.0% | +6.6% | -7.2% | +0.2% |
| Debt / equity | - | 0.91 | 0.89 | 1.00 | 1.18 | 1.23 | 1.10 |
| Long-term debt / equity | - | 0.48 | 0.66 | 0.84 | 1.00 | 1.07 | 0.97 |
| Interest cover | 40.27 | 52.72 | 38.07 | 88.94 | 66.41 | 291.44 | 103.93 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 1.34 | 1.36 | 0.81 | 0.58 | 0.46 | 0.55 |
| Inventory turnover | - | 5.63 | 5.76 | 4.40 | 5.95 | 4.06 | 4.71 |
| Debtors turnover | - | 6.29 | 8.17 | 5.52 | 5.17 | 5.21 | 5.78 |
| EPS (₹) | 4.68 | 4.10 | 5.39 | 0.96 | 1.95 | (2.17) | 0.07 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 41.48 | 37.41 | 32.22 | 31.21 | 30.15 | 33.65 |
To see the full year-wise statements and ratios of Lactose (India) Limited, buy the company report.
Board of directors of Lactose (India) Limited
Lactose (India) has 5 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Maheshwari Also directs: Solutix Technologies LLP | Managing Director | 11 Mar 1991 | 35 Years 7 Months | Current |
| Sangita Maheshwari Also directs: Vitanosh Ingredients Private Limited | Whole-Time Director | 24 Jan 2014 | 12 Years 9 Months | Current |
| Kishor Jivanbhai Patel Also directs: Jivanlakshmi Ventures LLP, Agnicores Stratoura Private Limited, Pioneer Clean Amps Private Limited and 2 more | Director | 22 Aug 2025 | 1 Years 2 Months | Current |
| Nandan Srinath | Director | 08 Aug 2024 | 2 Years 3 Months | Current |
| Chandra Mohan Bhagavatula Also directs: Micro Green Housing Finance Private Limited | Director | 08 Aug 2024 | 2 Years 3 Months | Current |
Peer comparison
Lactose (India) Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lactose (India) Limitedthis company | ₹163.29 Cr (FY 2026) | ₹6.06 Cr | 3.7% | 40.3% | 136 | Poicha, Gujarat, India |
| Kimia Biosciences Limited | ₹120.24 Cr (FY 2025) | 13.0% | Gurgaon, Haryana, India | |||
| Galaxy Laboratories Private Limited | ₹120.18 Cr (FY 2025) | 17.0% | Aurangabad, Maharashtra, India | |||
| Vartika Chemicals & Pharmaceuticals Private Limited | ₹120.07 Cr (FY 2025) | -17.0% | New Delhi, Delhi, India | |||
| Virchow Chemicals Pvt. Ltd. | ₹120.01 Cr (FY 2020) | -26.0% | Hyderabad, Telangana, India | |||
| Surya Life Sciences Limited | ₹118.61 Cr (FY 2025) | 12.0% | Navi Mumbai, Maharashtra, India | |||
| Prachem Laboratories Private Limited | ₹117.4 Cr (FY 2025) | -6.0% | Gandhinagar, Gujarat, India | |||
| Aastrid Life Sciences Private Limited | ₹115.25 Cr (FY 2025) | 6.0% | Navi Mumbai, Maharashtra, India | |||
| Element Chemilink Private Limited | ₹115.09 Cr (FY 2025) | 31.0% | Gujarat, India | |||
| Godavari Drugs Limited | ₹114.33 Cr (FY 2025) | -27.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Lactose (India) Limited, buy the company report.
Auditor
Lactose (India) Limited is audited by D M K H & Co. for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D M K H & Co. | FY 2025 | 116886W |
Shareholding
Shareholding for the quarter ended Mar 2026: promoters hold 53.60%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.60% and retail and other public shareholders hold 45.80%.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 53.60% | 53.60% | 53.60% | 53.60% |
| Public | 46.40% | 46.40% | 46.40% | 46.40% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jun 2026 | 101307428 | Others | ₹5.69 Cr | Open | |
| 30 Mar 2026 | 101282591 | Yes Bank Limited | ₹25 Cr | Open | |
| 30 Jun 2025 | 101122812 | Others | ₹20.72 Lakh | Open | |
| 23 Dec 2024 | 101029037 | Others | ₹15.39 Lakh | Open | |
| 29 Jul 2024 | 100966642 | Others | ₹40.65 Lakh | Open |
To see the full charge records of Lactose (India) Limited, buy the company report.
Total charge records: 30 View all charges
Deals & funding
Lactose (India) Limited has 8 deals on record (8 market trades); the latest was in February 2024.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2024 | Market trade | ₹1.28 Cr | Seller: an individual |
| Feb 2018 | Market trade | ₹1.31 Cr | Seller: Mangal Savitri Bizcon Private Limited |
| Sep 2017 | Market trade | ₹3.28 Cr | Buyer: Mangal Savitri Bizcon Private Limited |
| Jul 2017 | Market trade | ₹95.3 Lakh | Seller: Alaukik Mines & Power Private Limited |
| Jun 2017 | Market trade | ₹2.02 Cr | Buyer: Alaukik Mines & Power Private Limited , Mangal Savitri Bizcon Private Limited Seller: Mangal Savitri Bizcon Private Limited |
To see the full deal history of Lactose (India) Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Lactose (India) Limited has 44 court cases on record: 13 filed by Lactose (India), 31 filed against it. 12 cases are pending and 32 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 39 | 28 | 12 |
| High courts | 5 | 3 | 0 |
Cases on record (5 of 44)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Court case (REFER-T-LC) | Filed against the company by an individual | Pending |
| District court, Vadodara, Gujarat | Criminal complaint | Filed by the company against an individual | Pending |
| District court, Vadodara, Gujarat | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| District court, Vadodara, Gujarat | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| District court, Vadodara, Gujarat | Interim or miscellaneous application | Filed by the company against an individual | Pending |
To see the full case history of Lactose (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Lactose (India) Limited has 13 MSME Form 1 returns on record between 2018 and 2024, listing 393 overdue payments to 40 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 40)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Atmiya Wood Products | |||
| Jwala Logistic Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Adarsh Finetrade Private Limited |
To see the full MSME payment records of Lactose (India) Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Lactose (India) Limited has a workforce of 136 employees on its EPFO records as of Oct 10, 2025, across 1 active EPFO establishment.
GST
Lactose (India) has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACL2595G1ZL | Gujarat | Active | 01 Jul 2017 |
| 27AAACL2595G3ZD | Maharashtra | Active | 14 Mar 2018 |
To see the full GST registrations and return filing status of Lactose (India) Limited, buy the company report.
Recent activity
Lactose (India) Limited has 27 board changes on record since 1991: 16 appointments and 11 cessations. The latest: Dhaval Jayant Soni ceased to be Director on 07 Oct 2025.
80 earlier events are in the company report.
News
Frequently asked questions
Lactose (India) is an active public limited company based in Poicha, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 11 March 1991 (35+ years old) and is registered under CIN L15201GJ1991PLC015186. Listed on BSE: 524202.
Lactose (India) reported revenue of ₹163.29 Cr for FY 2025-26 (up 40.3% YoY) based on standalone financials.
Lactose (India) has 5 current directors:
- Atul Maheshwari - Managing Director
- Sangita Maheshwari - Whole-Time Director
- Kishor Jivanbhai Patel - Director
- Nandan Srinath - Director
- Chandra Mohan Bhagavatula - Director
The latest financial statements of Lactose (India) on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lactose (India) is 24AAACL2595G1ZL, registered in Gujarat. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 27AAACL2595G3ZD (Maharashtra).
The CIN (Corporate Identification Number) of Lactose (India) is L15201GJ1991PLC015186. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Lactose (India) is a listed company as per MCA records. Its shares are listed on BSE (code: 524202).
Lactose (India) has 44 court cases on record: 13 filed by the company and 31 filed against it. 12 are pending. Most are in the district courts.
Lactose (India) was incorporated on 11 March 1991, making it 35+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Lactose (India) has 8 deals on record (8 market trades); the latest was in February 2024.
The peers of Lactose (India) by revenue are Kimia Biosciences Limited, Galaxy Laboratories Private Limited, Vartika Chemicals & Pharmaceuticals Private Limited, Virchow Chemicals Pvt. Ltd, Surya Life Sciences Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dhaval Jayant Soni ceased to be Director on 07 Oct 2025. Kishor Jivanbhai Patel was appointed as Director on 22 Aug 2025. Gopal Krishan Sarda ceased to be Director on 12 Aug 2024. Lactose (India) has 27 board changes on record in total.

